| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.65 | 0.02 |